CAM
ABBV icon

Concorde Asset Management’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$521K Sell
2,896
-13
-0.4% -$2.34K 0.28% 60
2024
Q4
$517K Sell
2,909
-194
-6% -$34.5K 0.27% 60
2024
Q3
$613K Sell
3,103
-48
-2% -$9.48K 0.35% 49
2024
Q2
$540K Buy
3,151
+81
+3% +$13.9K 0.33% 54
2024
Q1
$559K Buy
3,070
+214
+7% +$39K 0.38% 47
2023
Q4
$443K Hold
2,856
0.3% 61
2023
Q3
$426K Sell
2,856
-20,503
-88% -$3.06M 0.38% 55
2023
Q2
$3.13M Sell
23,359
-6,317
-21% -$847K 2.89% 7
2023
Q1
$4.69M Buy
29,676
+27,677
+1,385% +$4.38M 5.56% 4
2022
Q4
$289K Buy
1,999
+42
+2% +$6.07K 0.26% 97
2022
Q3
$238K Buy
+1,957
New +$238K 0.27% 112
2022
Q2
Sell
-2,132
Closed -$317K 108
2022
Q1
$317K Buy
2,132
+578
+37% +$85.9K 0.21% 106
2021
Q4
$214K Sell
1,554
-1,104
-42% -$152K 0.13% 152
2021
Q3
$295K Buy
2,658
+639
+32% +$70.9K 0.17% 149
2021
Q2
$230K Sell
2,019
-8,131
-80% -$926K 0.13% 164
2021
Q1
$1.11M Buy
+10,150
New +$1.11M 0.64% 53
2020
Q3
Sell
-2,183
Closed -$209K 179
2020
Q2
$209K Buy
+2,183
New +$209K 0.17% 117
2020
Q1
Sell
-2,848
Closed -$250K 102
2019
Q4
$250K Sell
2,848
-182
-6% -$16K 0.17% 114
2019
Q3
$239K Sell
3,030
-721
-19% -$56.9K 0.18% 122
2019
Q2
$293K Buy
3,751
+54
+1% +$4.22K 0.17% 162
2019
Q1
$296K Sell
3,697
-193
-5% -$15.5K 0.19% 146
2018
Q4
$315K Buy
3,890
+333
+9% +$27K 0.27% 115
2018
Q3
$288K Buy
3,557
+795
+29% +$64.4K 0.28% 95
2018
Q2
$203K Sell
2,762
-159
-5% -$11.7K 0.23% 117
2018
Q1
$212K Sell
2,921
-170
-5% -$12.3K 0.26% 107
2017
Q4
$223K Buy
3,091
+5
+0.2% +$361 0.28% 97
2017
Q3
$244K Sell
3,086
-1,054
-25% -$83.3K 0.21% 120
2017
Q2
$301K Buy
+4,140
New +$301K 0.41% 87
2017
Q1
Sell
-4,072
Closed -$255K 113
2016
Q4
$255K Sell
4,072
-10,065
-71% -$630K 0.46% 82
2016
Q3
$892K Buy
+14,137
New +$892K 1.12% 25